Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.
about
Potential role of High mobility group box 1 in hepatocellular carcinomaSingle-Multiplex Detection of Organ Injury Biomarkers using SPRi based Nano-ImmunosensorEmerging role of HMGB1 in lung diseases: friend or foe.Etanercept blocks inflammatory responses orchestrated by TNF-α to promote transplanted cell engraftment and proliferation in rat liver.HMGB1-dependent and -independent autophagy.HMGB1 in health and disease.Sickle cell disease increases high mobility group box 1: a novel mechanism of inflammation.Hepatocyte-specific Hmgb1 DeletionNecrotic myocardial cells release damage-associated molecular patterns that provoke fibroblast activation in vitro and trigger myocardial inflammation and fibrosis in vivo.Ethanol and High Cholesterol Diet Causes Severe Steatohepatitis and Early Liver Fibrosis in Mice.Inhibition of HMGB1 release via salvianolic acid B-mediated SIRT1 up-regulation protects rats against non-alcoholic fatty liver disease.NKT cell modulates NAFLD potentiation of metabolic oxidative stress-induced mesangial cell activation and proximal tubular toxicityArtemisia annua Leaf Extract Attenuates Hepatic Steatosis and Inflammation in High-Fat Diet-Fed Mice.Inhibition of the translocation and extracellular release of high-mobility group box 1 alleviates liver damage in fibrotic mice in response to D-galactosamine/lipopolysaccharide challenge.Characterization of the Inflammatory Properties of Actively Released HMGB1 in Juvenile Idiopathic Arthritis.The mitochondria-targeted antioxidant MitoQ attenuates liver fibrosis in mice.Immune-mediated liver injury of the cancer therapeutic antibody catumaxomab targeting EpCAM, CD3 and Fcγ receptors.Novel chemokine-like activities of histones in tumor metastasis.Key Events Participating in the Pathogenesis of Alcoholic Liver Disease.HMGB1 release by H2O2-induced hepatocytes is regulated through calcium overload and 58-F interference.Blockade of high-mobility group box 1 attenuates intestinal mucosal barrier dysfunction in experimental acute pancreatitis.Mueller polarimetric imaging for surgical and diagnostic applications: a review.microRNA-218 suppresses the proliferation, invasion and promotes apoptosis of pancreatic cancer cells by targeting HMGB1.Dynamic localization and the associated translocation mechanism of HMGBs in response to GCRV challenge in CIK cells.Blockade of Notch signaling promotes acetaminophen-induced liver injury.Adsorption of the inflammatory mediator high-mobility group box 1 by polymers with different charge and porosity.Decreased serum platelet derived growth factor BB levels in acute and increased in chronic pancreatitis.High mobility group box 1 promotes sorafenib resistance in HepG2 cells and in vivo.Crosstalk between hepatitis B virus x and high-mobility group box 1 facilitates autophagy in hepatocytes.Necrostatin-1 Protects Against D-Galactosamine and Lipopolysaccharide-Induced Hepatic Injury by Preventing TLR4 and RAGE Signaling.Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology.Ischemic preconditioning attenuates acute lung injury after partial liver transplantation.Role of nonresolving inflammation in hepatocellular carcinoma development and progression.Profibrogenic effect of high-mobility group box protein-1 in human dermal fibroblasts and its excess in keloid tissues.Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma
P2860
Q26864508-44E96966-AA37-48BA-AE3D-BACBBF3BAA8DQ28315268-FB75B447-F7EF-4605-9DCA-21111272BE11Q33684145-AA0B6E26-AD0F-484C-8177-B4C4351813F3Q34250356-205CF9EB-00FD-42E3-8CCF-F1A9BF25032AQ34344751-E6C7D37D-049C-4EB3-8FAF-468DEF850B8BQ34622835-8DFF498E-F88E-4BB6-9130-744A0364E154Q34737543-AAD86792-86BE-49BA-84CA-30189256CDF7Q36111610-06AFA18D-3B1B-4BD2-860E-221C9CED3253Q36142000-0BD260EF-D603-4355-BBE8-BB924E170D26Q36146071-72FC5021-F1CD-475C-B422-DAFB72BC3E6FQ36242106-B3ECF2A6-77E6-4D3B-913E-9ABDB1125C95Q36363349-923DC2C1-0680-4B02-A748-E72A8AC7F5D7Q36705993-7418B621-261B-4AE9-80A8-761DDEE874F1Q36817465-A5247838-3324-4DEA-92BF-0894A7692040Q36827894-BDAC2C98-EFCE-4C48-B563-E75FF08B797AQ36879459-F1D62894-1492-43AB-AC84-52C825895D0AQ37317487-69017EBD-F4F9-4BAD-94EC-3D531A19E4FBQ37641674-136CF959-8C0E-4A8B-9A42-785B4F3A0136Q37729411-2BDD1040-984B-4D5F-BD8E-BB92666BB91FQ37742967-1C494456-E23D-48D0-98D1-E36F7748EB88Q38654274-EA6996F8-67EA-4C0A-956F-68B731E1AE81Q38688450-0B8ABB85-8AD1-4A5F-A169-EEFF45A4E61CQ38855169-55CE8AB7-9C67-4F46-925F-4769C476F364Q38973776-5D6E3FFF-98F8-481E-8358-91028E1F35CBQ40297124-DA710F46-9FDD-4420-913D-0991387C091CQ41965068-CB3392F2-DBB8-44F5-AE8A-7C96C5906486Q42918792-993DF311-3598-4302-AF11-422BEC28BC9CQ47135468-31E3AB30-7ED9-4E53-A993-2308E3E0ED40Q47217631-864D52AD-7709-4095-B3D5-DB72B7A4BF95Q48018174-06AAD580-4B26-44D8-937F-E3894E013D18Q54288262-AE86D3FC-D5BC-4049-AD38-382237B8C6DFQ55039365-BD8AE3A4-24CB-4C50-ADF8-917E429CC612Q55288642-3A0B8004-E2B2-4E2E-8267-A32E9DDBE54EQ55413894-9694CFDC-57A7-4964-9C11-D855A5C4050AQ58699656-B3E0556F-810E-434D-8E5D-4C8D80258D6F
P2860
Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.
@en
Emerging role of high-mobility group box 1
@nl
type
label
Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.
@en
Emerging role of high-mobility group box 1
@nl
prefLabel
Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.
@en
Emerging role of high-mobility group box 1
@nl
P2093
P2860
P1433
P1476
Emerging role of high-mobility group box 1 (HMGB1) in liver diseases.
@en
P2093
Daolin Tang
Qiuhong Zhang
Ruochan Chen
Xue-Gong Fan
P2860
P2888
P304
P356
10.2119/MOLMED.2013.00099
P407
P577
2013-11-08T00:00:00Z
P6179
1050928390